首页> 外文期刊>The pharmacogenomics journal >Association of polymorphisms in leptin and adiponectin genes with long-term outcomes in renal transplant recipients
【24h】

Association of polymorphisms in leptin and adiponectin genes with long-term outcomes in renal transplant recipients

机译:瘦素和脂联素基因多态性与肾移植受者的长期结果的关系

获取原文
获取原文并翻译 | 示例

摘要

The effect of polymorphims in leptin and adiponectin genes on long-term outcomes of renal transplantation is unknown. In 349 renal transplant recipients (RTR), we aimed to determine associations between five SNPs in the leptin receptor (LEPR) and adiponectin (ADIPOQ) genes and these outcomes. Follow-up time ranged from 2 to 25 years (mean 10.29 +/- 5.16 years). Two SNPs showed associations with long-term outcomes and their statistical significance greatly increased after 39 RTR with a history of cardiovascular events prior to transplantation were removed from the analysis. Adjusted odds ratios (OR) for LEPR rs1805094 and ADIPOQ rs1501299 and risk of graft loss were 0.35 (0.16-0.74) p = 0.006 and 2.37 (1.28-4.37) p = 0.006, respectively. The assessment of risk for global mortality revealed OR values of 0.20 (0.06-0.62), p = 0.005, and 2.43 (1.08-5.44), p = 0.031 for LEPR rs1805094 and ADIPOQ rs1501299, respectively. Our results show that polymorphism in genes involved in leptin and adiponectin function modify long-term outcomes in renal transplantation.
机译:瘦蛋白和脂联素基因对肾移植长期结果的影响是未知的。在349个肾移植受者(RTR)中,我们旨在确定瘦素受体(LEPR)和脂联素(AdipoQ)基因的五个SNP之间的关联和这些结果。随访时间从2到25年(平均10.29 +/- 5.16岁)。两种SNP显示出与长期结果的关联,并且在从分析中移除了移植前的心血管事件历史后,统计学显着性大大增加。调整后的遗漏比率(或)用于LEPR RS1805094和ADIPOQ RS1501299和接枝损失的风险分别为0.35(0.16-0.74)p = 0.006和2.37(1.28-4.37)p = 0.006。对全球死亡率风险的评估显示为0.20(0.06-0.62),P = 0.005和2.43(1.08-5.44),P = 0.031,分别为LEPR RS1805094和ADIPOQ RS1501299。我们的研究结果表明,参与瘦素和脂联素作用的基因中的多态性改性肾移植的长期结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号